AAAAAA
Results:
1-7
|
Results: 7
Authors:
Matzdorff, AC
White, JG
Malzahn, K
Greinacher, A
Citation: Ac. Matzdorff et al., Perioperative management of a patient with Fechtner syndrome, ANN HEMATOL, 80(7), 2001, pp. 436-439
Authors:
Matzdorff, AC
Kuhnel, G
Kemkes-Matthes, B
Voss, R
Citation: Ac. Matzdorff et al., Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid plateletfunction analyzer, J THROMB TH, 12(2), 2001, pp. 129-139
Authors:
Matzdorff, AC
Citation: Ac. Matzdorff, Evaluation of platelet activation in coronary artery disease - the role offlow cytometry, INFUS THER, 27(5), 2000, pp. 237-242
Authors:
Matzdorff, AC
Kuhnel, G
Kemkes-Matthes, B
Pralle, H
Voss, R
Fareed, J
Citation: Ac. Matzdorff et al., Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro, J LA CL MED, 135(3), 2000, pp. 247-255
Authors:
Keller, C
Matzdorff, AC
Kemkes-Matthes, B
Citation: C. Keller et al., Pharmacology of warfarin and clinical implications, SEM THROMB, 25(1), 1999, pp. 13-16
Authors:
Matzdorff, AC
Berchner, D
Kuhnel, G
Kemkes-Matthes, B
Pralle, H
Voss, R
Citation: Ac. Matzdorff et al., Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro, HAEMOSTASIS, 28(6), 1998, pp. 277-288
Authors:
Matzdorff, AC
Kemkes-Matthes, B
Pralle, H
Citation: Ac. Matzdorff et al., Reactivity of platelets from healthy individuals and from patients with hematologic diseases following incubation with pegylated recombinant human megakaryocyte growth and development factor in vitro, HAEMOSTASIS, 28(1), 1998, pp. 37-44
Risultati:
1-7
|